Singapore - English - HSA (Health Sciences Authority)

gen-y (s) pte. ltd. - orthopaedics - medicmicro power tool is designed for milling, sawing and screwing during surgery. mm950 (105.00.000) is designed to perform milling during percutaneous surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - ganciclovir sodium, quantity: 546 mg (equivalent: ganciclovir, qty 500 mg) - injection, powder for - excipient ingredients: - ganciclovir sxp (ganciclovir) administered as the iv infusion is indicated for the palliative treatment of confirmed sight-threatening cytomegalovirus (cmv) disease in aids and other severely immunocompromised individuals. it is indicated for the treatment of confirmed cmv pneumonitis in bone marrow transplant patients. it is also indicated for the prophylaxis of cmv infection and disease following bone marrow and solid organ transplantation in patients at risk of cmv disease.,note: ganciclovir sxp (ganciclovir) is not indicated for congenital or neonatal cmv disease; nor for the treatment of cmv infection in non-immunocompromised individuals.

Australia - English - Department of Health (Therapeutic Goods Administration)

maxx pharma pty ltd - opicapone, quantity: 50 mg - capsule, hard - excipient ingredients: titanium dioxide; pregelatinised starch; erythrosine; gelatin; magnesium stearate; lactose monohydrate; sodium starch glycollate type a; indigo carmine aluminium lake; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; pharmaceutical glaze; dimeticone - ongentys is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson?s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - ammonium chloride; codeine phosphate; diphenhydramine hcl - syrup - 135 mg/5 ml - ammonium chloride 135 mg/5 ml; codeine phosphate 5.7 mg/5 ml; diphenhydramine hcl 12.5 mg/5 ml

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - codeine phosphate; promethazine hcl - syrup - 9 mg/5 ml - codeine phosphate 9 mg/5 ml; promethazine hcl 3.6 mg/5 ml

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - codeine phosphate - elixir - 10 mg/5 ml - codeine phosphate 10 mg/5 ml

Singapore - English - HSA (Health Sciences Authority)

drug houses of australia pte. ltd. - pholcodine - syrup - 15 mg/5 ml - pholcodine 15 mg/5 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - latanoprost -

New Zealand - English - Medsafe (Medicines Safety Authority)

southern cross pharma nz ltd - ganciclovir sodium 543mg equivalent to 500 mg ganciclovir - powder for injection - 500 mg - active: ganciclovir sodium 543mg equivalent to 500 mg ganciclovir - ganciclovir sxp (ganciclovir) administered as the iv infusion is indicated for the palliative treatment of confirmed sight-threatening cytomegalovirus (cmv) disease in aids and other severely immunocompromised individuals. it is indicated for the treatment of confirmed cmv pneumonitis in bone marrow transplant patients. it is also indicated for the prophylaxis of cmv infection and disease following bone marrow and solid organ transplantation in patients at risk of cmv disease. note: ganciclovir sxp (ganciclovir) is not indicated for congenital or neonatal cmv disease; nor for the treatment of cmv infection in non-immunocompromised individuals.

Australia - English - Department of Health (Therapeutic Goods Administration)

specialised therapeutics pharma pty ltd - trabectedin, quantity: 1 mg - injection, powder for - excipient ingredients: monobasic potassium phosphate; sucrose; potassium hydroxide; phosphoric acid - yondelis is indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen.